Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Oct 27:8:3153-7.
doi: 10.2147/OTT.S90909. eCollection 2015.

Perineural invasion correlates with postoperative distant metastasis and poor overall survival in patients with PT1-3N0M0 esophageal squamous cell carcinoma

Affiliations

Perineural invasion correlates with postoperative distant metastasis and poor overall survival in patients with PT1-3N0M0 esophageal squamous cell carcinoma

Liming Sheng et al. Onco Targets Ther. .

Abstract

The aim of this study was to determine the prognostic value of perineural invasion (PNI) in patients with PT1-3N0M0 esophageal squamous cell carcinoma (ESCC) who underwent curative resection. A total of 148 patients with PT1-3N0M0 ESCC, who underwent surgery in Zhejiang Cancer Hospital (Hangzhou, People's Republic of China), between 2006 and 2009, were evaluated in this retrospective study. The effects of PNI on distant metastasis-free survival (DMFS) and overall survival (OS) were assessed using Kaplan-Meier analysis. Independent prognostic factors were identified by multivariate Cox analysis. Positive PNI was identified in 25.0% of all the cases. The depth of invasion (PT stage) was closely associated with the PNI positivity (P<0.001). The 5-year DMFS rate and OS rate of the PNI-positive patients were significantly worse than those of the PNI-negative patients (DMFS: 37.2% vs 62.3%, P=0.009; OS: 31.3% vs 74.3%, P,0.001). Multivariate analysis indicated that the positivity of PNI was an independent prognostic factor for both DMFS (hazard ratio [HR] =2.35, P=0.039) and OS (HR =3.56, P=0.002). Our results suggest that PNI was a predictor of distant metastasis and independently associated with prognosis of patients with PT1-3N0M0 ESCC.

Keywords: esophageal squamous cell carcinoma; metastasis; perineural invasion; prognosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
DMFS curve subdivided by PNI in PT1–3N0 ESCC. Note: Patients with PNI-positive tumors showed significantly poorer DMFS than those with PNI-negative tumors (P=0.009, log-rank test). Abbreviations: DMFS, distant metastasis-free survival; PNI, perineural invasion; ESCC, esophageal squamous cell carcinoma.
Figure 2
Figure 2
OS curve subdivided by PNI in PT1–3N0 ESCC. Note: Patients with PNI-positive tumors showed significantly poorer OS than those with PNI-negative tumors (P<0.001, log-rank test). Abbreviations: PNI, perineural invasion; OS, overall survival; ESCC, esophageal squamous cell carcinoma.

References

    1. Ariga H, Nemoto K, Miyazaki S, et al. Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys. 2009;75:348–356. - PubMed
    1. Lin Y, Su X, Su H, et al. Prediagnostic smoking and postoperative survival in lymph node-negative esophagus squamous cell carcinoma patients. Cancer Sci. 2012;103:1985–1988. - PMC - PubMed
    1. Song Z, Wang J, Lin B, Zhang Y. Analysis of the tumor length and other prognosis factors in pt1–2 node-negative esophageal squamous cell carcinoma in a Chinese population. World J Surg Oncol. 2012;10:273. - PMC - PubMed
    1. Ando N, Kato H, Igaki H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (jcog9907) Ann Surg Oncol. 2012;19:68–74. - PubMed
    1. Zafirellis K, Dolan K, Fountoulakis A, Dexter SP, Martin IG, Sue-Ling HM. Multivariate analysis of clinical, operative and pathologic features of esophageal cancer: who needs adjuvant therapy? Dis Esophagus. 2002;15:155–159. - PubMed

LinkOut - more resources